Everett Harris & CO Gsk PLC Transaction History

Everett Harris & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$36.52 - $41.46 $4,345 - $4,933	-119 Reduced 0.87%	13,546 $539,000
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $5,106 - $5,961	-149 Reduced 1.08%	13,665 $488,000
Q4 2020 Feb 04, 2021	BUY	$34.07 - $39.94 $19,113 - $22,406	561 Added 4.23%	13,814 $508,000
Q1 2020 Apr 29, 2020	BUY	$32.47 - $48.83 $97,734 - $146,978	3,010 Added 29.39%	13,253 $502,000
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $96,648 - $104,743	2,453 Added 31.49%	10,243 $410,000
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $15,119 - $17,076	-400 Reduced 4.88%	7,790 $298,000
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $2,981 - $3,201	-75 Reduced 0.91%	8,190 $329,000
Q2 2018 Jul 27, 2018	BUY	$39.61 - $42.76 $15,844 - $17,104	400 Added 5.09%	8,265 $333,000
Q1 2018 Apr 20, 2018	BUY	$36.18 - $40.15 $284,555 - $315,779	7,865 New	7,865 $307,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

Stay updated on Everett Harris & CO with notifications on news.